Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 45 Records) |
Query Trace: Lung Neoplasms and ABCB1[original query] |
---|
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2015 May 29 (5): 1986-98. Xiang Chan, Wang Jiucun, Kou Xiaochen, Chen Xiabin, Qin Zhaoyu, Jiang Yan, Sun Chang, Xu Jibin, Tan Wen, Jin Li, Lin Dongxin, He Fuchu, Wang Haiji |
Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy. Pharmacogenetics and genomics 2015 Dec . Park Hyung Soon, Lim Sun Min, Cho Arthur, Shin Jae-Gook, Lee Min Goo, Kim Hye Ryun, Kim Joo Hang, Shin Ho Jung, Cho Byoung Ch |
Predicting chemosensitivity to gemcitabine and cisplatin based on gene polymorphisms and mRNA expression in non-small-cell lung cancer cells. Pharmacogenomics 2015 1 16 (1): 23-34. Meng Xiangning, Wang Geng, Guan Rongwei, Jia Xueyuan, Gao Wei, Wu Jie, Yu Jingcui, Liu Peng, Yu Yang, Sun Wenjing, Dong Haiying, Fu Songb |
Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer. Clinical lung cancer 2015 Jul 16 (4): 274-81. Kobayashi Hiroyuki, Sato Kazuhiro, Niioka Takenori, Miura Hajime, Ito Hiroshi, Miura Masato |
Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients. Chinese journal of cancer 2016 35 (1): 85. Qian Chen-Yue, Zheng Yi, Wang Ying, Chen Juan, Liu Jun-Yan, Zhou Hong-Hao, Yin Ji-Ye, Liu Zhao-Qi |
Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism. Cancer science 2016 Jun . Fujiwara Yutaka, Hamada Akinobu, Mizugaki Hidenori, Aikawa Hiroaki, Hata Toshiyuki, Horinouchi Hidehito, Kanda Shintaro, Goto Yasushi, Itahashi Kota, Nokihara Hiroshi, Yamamoto Noboru, Ohe Yuichi |
Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transporters. The pharmacogenomics journal 2016 Apr . Ma Y, Xin S, Huang M, Yang Y, Zhu C, Zhao H, Zhang Y, Chen L, Zhao Y, Li J, Zhuang W, Zhu X, Zhang L, Wang |
Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2016 Mar 93 69-76. Hirose Takashi, Fujita Ken-Ichi, Kusumoto Sojiro, Oki Yasunari, Murata Yasunori, Sugiyama Tomohide, Ishida Hiroo, Shirai Takao, Nakashima Masanao, Yamaoka Toshimitsu, Okuda Kentaro, Ohmori Tohru, Sasaki Yasutsu |
Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer. Integrative cancer therapies 2018 9 17 (4): 1109-1114. Lu Hongyang, Qin Jing, Han Na, Xie Fajun, Gong Lei, Li Chengh |
Effects of OPRM1 and ABCB1 gene polymorphisms on the analgesic effect and dose of sufentanil after thoracoscopic-assisted radical resection of lung cancer. Bioscience reports 2019 01 39 (1): . Zhao Zhonghai, Lv Bin, Zhao Xiaodong, Zhang Yunlo |
Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters. Biological & pharmaceutical bulletin 2018 41 (1): 47-56. Endo-Tsukude Chihiro, Sasaki Ji-Ichiro, Saeki Sho, Iwamoto Norihiro, Inaba Megumi, Ushijima Sunao, Kishi Hiroto, Fujii Shinji, Semba Hiroshi, Kashiwabara Kosuke, Tsubata Yukari, Hayashi Mitsuhiro, Kai Yuki, Saito Hideyuki, Isobe Takeshi, Kohrogi Hirotsugu, Hamada Akino |
Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2019 7 134 1-6. Hayashi Hideki, Iihara Hirotoshi, Hirose Chiemi, Fukuda Yoshihisa, Kitahora Mika, Kaito Daizo, Yanase Komei, Endo Junki, Ohno Yasushi, Suzuki Akio, Sugiyama Tadas |
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study. Cancer chemotherapy and pharmacology 2019 Feb . De Troia Beatrice, Dalu Davide, Filipazzi Virginio, Isabella Luigi, Tosca Nicoletta, Ferrario Sabrina, Gambaro Anna Rita, Somma Luisa, Fasola Cinzia, Cheli Stefania, Clementi Emilio, De Francesco Davide, Falvella Felicia Stefania, Cattaneo Maria Tere |
ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy. Thoracic cancer 2019 Sep . Zhong Jia, Guo Zihan, Fan Liping, Zhao Xinghui, Zhao Bingqing, Cao Zhigang, Cheng Linlin, Shi Yuanyuan, Li Xiaoting, Zhang Yanhua, An Tongtong, Wu Meina, Wang Yuyan, Zhuo Minglei, Li Jianjie, Yang Xue, Chen Hanxiao, Jia Bo, Zhao J |
Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Patients. Frontiers in pharmacology 2020 11 664. Liao Dehua, Liu Zhigang, Zhang Yongchang, Liu Ni, Yao Dunwu, Cao Lizhi, Chen Yun, Fu Yilan, Yang Nong, Xiang Daxio |
Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea. In vivo (Athens, Greece) 0 34 (3): 1415-1419. Sogawa Rintaro, Nakashima Chiho, Nakamura Tomomi, Takeuchi Koji, Kimura Sakiko, Komiya Kazutoshi, Narisawa Yutaka, Kimura Shinya, Sueoka-Aragane Nao |
The impact of ABCB1 gene polymorphism and its expression on non-small-cell lung cancer development, progression and therapy - preliminary report. Scientific reports 2020 4 10 (1): 6188. Zawadzka Izabela, Jele? Agnieszka, Pietrzak Jacek, ?ebrowska-Nawrocka Marta, Michalska Katarzyna, Szmajda-Krygier Dagmara, Mirowski Marek, ?ochowski Mariusz, Kozak Józef, Balcerczak E |
The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort study. Annals of translational medicine 2019 Dec 7 (24): 806. Ma Yuxiang, Xin Shuang, Lin Qingguang, Zhuang Wei, Zhao Yuanyuan, Zhu Xia, Zhao Hongyun, Huang Min, Xun Xu, Yang Yunpeng, Fang Wenfeng, Zhang Li, Wang Xuedi |
[Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor]. Zhonghua yi xue za zhi 2020 11 100 (42): 3323-3327. Mi R H, Dang H B, Chen L, Han Y L, Wang M F, Zhang Y L, Chen L, Li D B, Wei X |
Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population. Heliyon 2021 Sep 7 (9): e07867. Veiskarami Parisa, Houshmand Massoud, Seifi Sharareh, Ansarinejad Nafiseh, Fardad Farshid, Abbasi Bahar |
Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer. Investigational new drugs 2022 9 40 (6): 1254-1262. Yokota Hayato, Sato Kazuhiro, Sakamoto Sho, Okuda Yuji, Fukuda Natsuki, Asano Mariko, Takeda Masahide, Nakayama Katsutoshi, Miura Masato |
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology 2022 12 e23269. Sharma Parul, Singh Navneet, Sharma Siddhar |
Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study. BMC pulmonary medicine 2022 11 22 (1): 454. Nio Yuta, Ishida Hiroo, Matsumoto Natsumi, Kusumoto Sojiro, Kubota Yutaro, Tsunoda Takuya, Sasaki Yasutsuna, Fujita Ken-Ic |
Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. The journal of gene medicine 2022 10 25 (1): e3460. Sharma Parul, Singh Navneet, Sharma Siddhar |
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
The Interaction between Four Polymorphisms and Haplotype of ABCB1, the Risk of Non-Small Cell Lung Cancer, and the Disease Phenotype. Journal of oncology 2023 2 2023 7925378. Jele? Agnieszka, ?ebrowska-Nawrocka Marta, Sa?agacka-Kubiak Aleksandra, Zawadzka Izabela, ?ochowski Mariusz, Balcerczak E |
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study. Investigational new drugs 2023 1 . Ishikawa Emi, Yokoyama Yuta, Chishima Haruna, Kasai Hidefumi, Kuniyoshi Ouki, Kimura Motonori, Hakamata Jun, Nakada Hideo, Suehiro Naoya, Nakaya Naoki, Nakajima Hideo, Ikemura Shinnosuke, Kawada Ichiro, Yasuda Hiroyuki, Terai Hideki, Jibiki Aya, Kawazoe Hitoshi, Soejima Kenzo, Muramatsu Hiroshi, Suzuki Sayo, Nakamura Tomono |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: